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oss of tissue polarity and increased proliferation are
the characteristic alterations of the breast tumor
phenotype. To investigate these processes, we used a
three-dimensional (3D) culture system in which malignant
human breast cells can be reverted to a normal phenotype
by exposure to inhibitors of phosphatidylinositol 3-kinase
(PI3K). Using this assay, we ﬁnd that Akt and Rac1 act as
downstream effectors of PI3K and function as control points
of cellular proliferation and tissue polarity, respectively.
Our results also demonstrate that the PI3K signaling
L
 
pathway is an integral component of the overall signaling
network induced by growth in 3D, as reversion affected
by inhibition of PI3K signaling also down-modulates the
endogenous levels of 
 
 
 
1 integrin and epidermal growth
factor receptor, the upstream modulators of PI3K, and
up-regulates PTEN, the antagonist of PI3K. These ﬁndings
reveal key events of the PI3K pathway that play distinct
roles to maintain tissue polarity and that when disrupted
are instrumental in the malignant phenotype.
 
Introduction
 
Class I phosphatidylinositol 3-kinase (PI3K) is activated
by growth factor–responsive tyrosine kinases such as epider-
mal growth factor receptor (EGFR; Grant et al., 2002) and
integrin-responsive kinases such as focal adhesion kinase
(FAK; Chen and Guan, 1994). Activated PI3K leads to the
production of membrane-associated phosphatidylinositol
3,4,5-trisphosphate (PIP3), which in turn causes the recruit-
ment to the cell membrane and subsequent activation of a
number of signaling molecules (Vivanco and Sawyers, 2002).
PI3K is a key mediator in processes that regulate cell orienta-
tion; for both 
 
Dictyostelium
 
 and cultured human leukocytes,
directionality of chemotaxis is controlled by polarization of
PIP3 to the leading edge of the cell (Servant et al., 2000;
Funamoto et al., 2002; Wang et al., 2002b). PI3K has been
found to be constitutively up-regulated in a substantial
fraction of human breast cancers (Vivanco and Sawyers,
2002), and overexpression of PI3K in cultured nonmalignant
human mammary epithelial cells is sufficient to confer a
malignant phenotype (Zhao et al., 2003).
During tumor progression, tissue polarity is lost and
control of proliferation is compromised (Fish and Molitoris,
1994; Reichmann, 1994; Bissell and Radisky, 2001), and
although these two phenomena have been suggested to be
linked, previous investigations have not revealed the extent
to which the increased cellular proliferation in tumors can
directly produce tissue disorganization, and to what extent
loss of polarity is an independent function of deregulated
signaling pathways downstream of the oncogenic signal(s).
To dissect the molecular mediators of these processes we
have used an assay (Petersen et al., 1992) in which human
mammary epithelial cells from the HMT-3522 tumor
progression series are cultured in a physiologically relevant,
three-dimensional (3D) laminin-rich basement membrane
(lrBM). When cultured in 3D lrBM, the phenotypically
normal, nonmalignant HMT-3522 S-1 (S-1) cells undergo
growth arrest, produce an endogenous basement membrane,
and form polarized acinus-like structures, very similar to
primary cells from reduction mammoplasty. In contrast, the
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malignant HMT-3522 T4-2 (T4-2) cells continue to prolif-
erate into apolar, amorphous structures, similar to structures
formed by primary tumor cells in this assay (Petersen et al.,
1992). In comparison to S-1 cells, expression levels of EGFR
and 
 
 
 
1 integrin in T4-2 cells are greatly increased, and
down-regulation of these signaling pathways in T4-2 cells
grown in 3D lrBM can restore the formation of polarized
acinus-like structures, resulting in a reversion similar to the
normal phenotype of the S-1 cells (Weaver et al., 1997;
Wang et al., 1998).
As PI3K is activated downstream of both EGFR and 
 
 
 
1
integrin (Chen and Guan, 1994; Lee and Juliano, 2000;
Grant et al., 2002), we hypothesized that the phenotypic re-
version affected by down-modulation of EGFR/
 
 
 
1 integrin
signaling in T4-2 cells was due to attenuation of PI3K activ-
ity. We showed previously that even highly malignant meta-
static cancer cells, cultured in 3D lrBM, could be reverted to
a normal phenotype by inhibition of PI3K, if treatment with
PI3K inhibitors was performed in combination with appro-
priate manipulation of other signaling pathways (Wang et
al., 2002a). Here we use inhibition of PI3K alone to dissect
the signaling pathways that control proliferation and polar-
ity in breast tumor cells. Our results reveal a new functional
link between extracellular signaling mediators and tissue
function that provides insight into processes that control the
malignant phenotype if imbalanced. We also show that the
PI3K and its lipid product, PIP3, are relocalized to the basal
surface of the acini when the malignant cells are reverted in
lrBM, a process that may play a role in integration of signal-
ing pathways in reformation of polarity.
 
Results
 
Down-modulation of PI3K activity results in phenotypic 
reversion of human mammary tumor cells
 
We found previously that malignant T4-2 cells showed in-
creased signaling from EGFR and 
 
 
 
1 integrin, relative to
their nonmalignant predecessors, and that down-modula-
tion of either EGFR or 
 
 
 
1 integrin activity in cells grown in
3D lrBM caused the cells to form growth-arrested, polarized
acinus-like structures (Weaver et al., 1997; Wang et al.,
1998). As PI3K is an effector of both of these signaling path-
ways (Chen and Guan, 1994; Lee and Juliano, 2000; Grant
et al., 2002), we hypothesized that inhibition of PI3K sig-
naling would also revert these cells. We found that treatment
of T4-2 cells with 8 
 
 
 
M of the PI3K inhibitor LY294002
(which prevented phosphorylation of downstream Akt at
serine 473, as well as other downstream signaling mediators
glycogen synthase kinase-3
 
 
 
 [GSK-3
 
 
 
] and p70S6K; Fig. 1
B) did cause phenotypic reversion, as characterized by inhi-
bition of proliferation, decreased colony size, and reduced
growth in soft agar cultures (Fig. 1, A and C). Using indirect
immunofluorescence, we found that the LY294002-reverted
T4-2 cells regained the polarization of the apicolateral tight
junction marker ZO-1, the basal marker 
 
 
 
6 integrin, and
the reorganization of the actin cytoskeleton (Fig. 2 A). Simi-
lar data were obtained in cells treated with the alternative
PI3K inhibitor, wortmannin (unpublished data). These re-
sults demonstrate that down-regulation of the PI3K path-
way in T4-2 mammary tumor cells restores an intrinsic
property of forming polarized, growth-arrested structures in
response to a physiologically relevant microenvironment.
 
Phenotypic reversion is accompanied by repolarization 
of PI3K and its phospholipid product
 
Proper interpretation of extracellular signaling cues requires
asymmetric distribution of intracellular signaling molecules
(Comer and Parent, 2002; Wedlich-Soldner and Li, 2003).
Recently, signaling asymmetry of PI3K and its lipid prod-
uct, PIP3 has been shown to control the directionality of
chemotactic migration in human neutrophils and in single
 
Dictyostelium
 
 cells (Servant et al., 2000; Funamoto et al.,
2002; Wang et al., 2002b), and PIP3 has been found to be-
come polarized to the basal surface of MDCK cells grown as
monolayers on filters or in 3D collagen gels (Watton and
Downward, 1999; Yu et al., 2003). We found that both
PI3K (p85 subunit) and PIP3 are polarized to the basal sur-
face of phenotypically normal S-1 cells grown in 3D lrBM,
and that this asymmetric distribution is lost in T4-2 cells
(Fig. 2 B). However, phenotypic reversion of the T4-2 cells
through attenuation of PI3K signaling led to repolarization
of these signaling components (Fig. 2 B). Given that the S-1
and reverted T4-2 cells show correct tissue polarity, whereas
the untreated T4-2 cells are apolar, these results provide the
Figure 1. Attenuation of PI3K activity results in phenotypic reversion 
of HMT-3522 T4-2 human mammary tumor cells cultured in 3D BM. 
(A) Phase contrast micrographs of 10-d 3D lrBM cultures of pheno-
typically normal (S-1), malignant (T4-2), and T4-2 cells treated with 
8  M PI3K inhibitor, LY294002 (T4-2 LY). Bar, 20  m. (B) Cell 
lysates from 10-d 3D lrBM cultures were analyzed for phosphorylated 
Akt (serine 473)/total, phosphorylated GSK-3  (serine 9)/total, and 
phosphorylated p70 S6 kinase (threonine 389)/total by Western blot. 
(C) Inhibition of PI3K causes a reduction in cellular proliferation 
(left, BrdU labeling assay, n   3), colony size (center, 50 colonies
assessed for each experiment, n   3), and anchorage-independent 
growth (right, soft agar assay, colonies scored positive when  50  m, 
n   3). 
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first evidence that polarized distribution of PI3K and PIP3 is
an intrinsic property of phenotypically normal acini that is
lost during tumor progression.
 
Phenotypic reversion of T4-2 cells by treatment 
with LY294002 results in cross-modulation of 
multiple signaling pathways
 
We had shown previously that inhibition of either EGFR or
 
 
 
1-integrin results in phenotypic reversion of T4-2 cells as-
sociated with down-modulation of the total levels of both
signaling molecules, and that this activity influences and is
influenced by the MAPK signaling pathway (Wang et al.,
1998). We now show that PI3K signaling is also an integral
component of this cross-modulated signaling network. T4-2
cells treated with LY294002 show reduced levels of EGFR
and 
 
 
 
1 integrin (Fig. 3 A). This effect depended upon 3D
lrBM as it is not observed in cells cultured on two-dimen-
sional (2D) plastic substrata (it should be noted that inhibi-
tion of PI3K activity, as measured by activation of down-
stream mediators Akt and GSK-3
 
 
 
, was equally effective in
cells on 2D or in 3D; Fig. 3 A). In addition, our results re-
vealed that PTEN, the antagonist of PI3K that acts to de-
phosphorylate PIP3 and which becomes down-regulated in
many carcinomas (Simpson and Parsons, 2001; Yamada
and Araki, 2001), is also a component of the cross-modu-
lated signaling network, as treatment of T4-2 cells with
LY294002 resulted in an increase of PTEN to the level of
the nonmalignant cells; this modulation, too, was seen only
in cells cultured on 3D lrBM (Fig. 3 B). Taken together,
these results demonstrate the existence of a retrodirectional
control network that exists only when cells are cultured in a
proper tissue context.
 
Increased proliferation and loss of tissue polarity 
are functionally separable consequences of increased 
PI3K signaling
 
PI3K has been found to control a wide variety of downstream
signal transduction pathways, the number and composition
of which vary according to cell and tissue type (Chan et al.,
1999; Vanhaesebroeck et al., 2001). The best-studied effec-
tor of PI3K is Akt, a regulator of cellular proliferation and
apoptosis (Scheid and Woodgett, 2001). We examined the
Figure 2. Inhibition of PI3K results in reestablish-
ment of tissue polarity. (A) Down-modulation of 
PI3K activity of T4-2 cells was sufficient to repolarize 
the apicolateral tight junction protein ZO-1 and the 
basal ECM receptor,  6 integrin, and to result in the 
reorganization of the actin cytoskeleton. (B) PI3K 
and its phospholipid product, PIP3, are basolaterally 
localized in S-1 acini, apolarly distributed in the 
T4-2 colonies, and normalized in the reverted T4-2 
structures. For both A and B, S-1, T4-2, and T4-2  
LY (revertants) were cultured for 10 d in 3D lrBM. 
 6 integrin, ZO-1, actin, PI3K p85 subunit, and 
PIP3 were stained by specific antibodies and phal-
loidin-FITC, and imaged by confocal fluorescence 
microscopy. Bars, 10  m. 
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possibility that the PI3K inhibitor-mediated reversion was
due to reduction of Akt activity by expressing a dominant ac-
tive Akt construct (Myr-Akt) in the T4-2 cells (Fig. 4 A). Ex-
pression of this construct blocked the effect of PI3K inhibitor
on phosphorylation of Akt and downstream mediators of Akt
activity (Fig. 4 B), and substantially increased the prolifera-
tion of T4-2 cells (Fig. 4, C and D). However, examination
of colony polarity revealed that the LY294002-treated T4-
Myr-Akt cell spheroids largely retained basal tissue polarity
despite their considerably larger size (Fig. 4, E and F). This
result revealed that increased proliferation alone was not suf-
ficient to disrupt tissue polarity in the reverted T4-2 cells
(which retain all of their phenotype-altering genetic muta-
tions), and suggested that other effectors of PI3K might be
responsible for disruption of tissue polarity.
Recent investigations of acinus-like cysts of MDCK cells
grown in 3D collagen gels have demonstrated a role for Rac1
in control of cellular polarity (O’Brien et al., 2001). When
we examined the activity of Rac1 in S1, T4-2, and
LY294002-reverted T4-2 cells using pull-down assays, we
found a high correlation of active Rac1 levels with loss of tis-
sue polarity (Fig. 5 A). To test the role of Rac1 in the rever-
sion phenotype, we expressed a dominant active Rac1 con-
struct in T4-2 cells (Rac1L61; Fig. 5 B). We found that this
construct did not greatly affect the rate of cellular prolifera-
tion (Fig. 5, C and D), but did inhibit the restoration of po-
larity in response to LY294002 (Fig. 5, E and F). Although
the inhibition of reversion by the Rac1L61 was incomplete,
this was most likely due to the heterogenous expression of
this construct in the target cell population (assessed by im-
munofluorescence; unpublished data). As a complementary
method to validate this result, we also found that infection
with an adenovirus containing Rac1V12, which was ex-
pressed in a much higher proportion of the cells, showed
much greater resistance to LY294002-mediated reversion of
polarity (Fig. S1 C, available at http://www.jcb.org/cgi/
content/full/jcb.200306090/DC1).
These results demonstrated that the increased PI3K sig-
naling in T4-2 cells, relative to the same cells treated with
LY294002 or to the nonmalignant S-1 cells, leads to activa-
tion of both Rac1 and Akt, and that these effectors signal to
two functionally distinct phenotypes: activation of Rac1
causes the loss of cellular polarity, and activation of Akt
causes increased proliferation. To determine whether to-
gether these two effectors were sufficient to recapitulate the
effects of PI3K, T4-2 cells were infected with both con-
structs (Fig. 6 A). Colonies derived from cells transfected
with these constructs were considerably larger than from
control vector-infected cells. Treatment with PI3K inhibitor
reduced the increased proliferation only to the level of the
malignant vector-transfected cells (Fig. 6, B and C), but it
had no repolarizing effect (Fig. 6 D). To determine whether
these effects were also manifested in a different surrogate tu-
mor malignancy assay, the four cell types (T4-2, T4
 
 
 
Myr-
Akt, T4
 
 
 
Rac1L61, and T4
 
 
 
MyrAkt
 
 
 
Rac1L61) were cul-
tured in 3D methylcellulose in the absence or presence of
LY294002 (Fig. 6 E, 
 
 
 
LY and 
 
 
 
LY). In this assay as well,
we found that combined expression of both constructs com-
pletely abrogated the effects of LY294002 treatment.
 
Discussion
 
A number of studies have shown that the PI3K signaling
pathway becomes dysregulated in many types of carcinoma
(Vivanco and Sawyers, 2002). The results presented here de-
fine mechanisms by which the high activity of PI3K in ma-
lignant T4-2 human breast cells contributes to their malig-
nant phenotype. We find that down-modulation of PI3K
activity in the T4-2 cells grown in 3D lrBM causes struc-
tural repolarization and reversion to a nonmalignant pheno-
type (Fig. 1) similar to the effects observed previously from
inhibition of EGFR and 
 
 
 
1 integrin (Weaver et al., 1997;
Wang et al., 1998), and we additionally show that both the
normal and the normalized reverted acinus-like structures
had basal polarization of PI3K and its lipid signaling prod-
uct, PIP3 (Fig. 2 B). The evidence that inhibition of PI3K
can affect crossmodulation of a number of distinct signaling
pathways is a demonstration that pathways downstream of
PI3K are integrated into transduction networks when cells
are grown in the physiological 3D lrBM; consistent with this
model, we found that reversion of the tumor cells to a nor-
mal phenotype was associated with increased expression of
PTEN, the PI3K antagonist (Fig. 3 B). Looking for the sig-
naling effectors that controlled the increased proliferation
and decreased polarity downstream of PI3K in the T4-2 cells
led to identification of Akt as a mediator of increased prolif-
eration (Fig. 4) and Rac1 as an inhibitor of polarization (Fig.
5), and we found that these two genes, when expressed in
combination, were sufficient to overcome the inhibition of
Figure 3. Attenuation of PI3K activity results in cross-modulation 
of other signaling pathways and intermediates. Cell lysates from S-1, 
T4-2, and T4-2 LY grown in 3D lrBM or on 2D plastic substrata for 
10 d were analyzed for expression of (A) EGFR,  1 integrin, phos-
phorylated Akt (serine 473)/total, phosphorylated GSK-3  (serine 9)/
total, and (B) PTEN (n   3); E-cadherin was used as the loading con-
trol. It was shown previously that the total level of E-cadherin 
does not change under these conditions (Weaver et al., 1997). 
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PI3K (Fig. 6). These results suggest a model in which the
key aspects of the early malignant phenotype, growth and
disorganization, can be controlled through disruption of sig-
naling pathways that become interconnected and integrated
in 3D lrBM (Fig. 7).
It is an important consideration, however, that the progres-
sively increased proliferation and disorganization that typify
acquisition of malignancy in mammary epithelial cells is due
to more than just PI3K-dependent activation of Rac1 and
Akt (although combined activation of these two pathways
has been shown to be sufficient to confer malignancy in an
experimental model of premalignant human mammary epi-
thelial cells; Zhao et al., 2003). During tumor progression
there are many genetic and epigenetic alterations that to-
gether contribute to produce malignancy; for the progression
of S-1 to T4-2 cells, these include induction of many path-
ways likely not directly related to PI3K signaling. Reversion
of the T4-2 tumor cells grown in 3D suppresses most (if not
all) of these other pathways, reducing the proliferation and
restoring polarity, but does not change the fact that the re-
verted cells still retain all of the same genetic alterations and
abnormalities. Thus, reversion (whether by LY294002 or by
any other T4-2 reversion reagent) results in a cell system that
is genetically malignant but biochemically normal, and the
consequences of manipulating a single signaling pathway in
reverted cells provides information directly relevant to basic
characteristics of malignant cell behavior. Using this model,
we now show how the altered signaling pathways in T4-2 tu-
mor cells may contribute to the tumor phenotype, how the
functions of master regulators (such as PI3K) may be dis-
sected in terms of downstream signaling pathways (in this
case, Rac1 and Akt), and how manipulation of these path-
ways can cause the tumor cells to adopt a normal phenotype.
Normalization of signaling pathways in T4-2 cells in re-
sponse to inhibition of PI3K is dependent upon culture in
3D lrBM, as T4-2 cells grown on 2D tissue culture plastic do
not show the dramatic downmodulation of 
 
 
 
1 integrin and
EGFR (Fig. 3 A), up-regulation of PTEN (Fig. 3 B), or the
alterations in cellular morphology in response to treatment
with inhibitors of PI3K (Figs. 2 and 3). Also, for T4-2 cells
grown in 3D lrBM, the reduction in PI3K signaling is paral-
leled by a reorganization of signaling orientation, as both
PI3K and its phospholipid product, PIP3, became repolar-
ized to the basolateral surface of the reorganized T4-2 cell
Figure 4. Expression of Akt increases proliferation 
but does not affect polarity. (A) Expression of 
constitutively active Akt in T4-2 cells (Myr-Akt), 
detected by Western analysis of cells infected with 
Myr-Akt ( ) or vector control ( ), and probed with 
anti-Akt (left) or anti-HA antibodies (right). (B) Activity 
of Myr-Akt mutant and its downstream target were 
not affected by PI3K inhibitor LY294002; cell lysates 
from T4-2 and T4-2 LY expressing Myr-Akt or 
vector grown in 3D lrBM for 10 d were analyzed for 
phosphorylated Akt (serine 473)/total and GSK-3  
(serine 9)/total. (C) T4 Myr-Akt colonies were larger 
than control (T4-2 Vector) colonies, both in the 
presence and absence of LY294002, as assessed by 
phase contrast microscopy. Bar, 20  m. (D) T4-2   
Myr-Akt colonies had more nuclei per spheroid 
cross section. Total nuclear number at spheroid 
cross section and spheroid numbers were counted 
and are presented as cell number per spheroid cross 
section. Statistical analyses revealed significant 
differences between Myr-Akt and vector control 
(mean   SD, P values calculated using Student’s t 
test; more than 500 colonies from 5 independent 
experiments were analyzed for each condition). 
(E) Constitutively active Akt signaling did not affect 
the basal tissue repolarization when T4-2 Myr-Akt 
cells were reverted by PI3K inhibitor, as assessed by 
basal localization of  6 integrin relative to DAPI-
stained nuclei. Bar, 10  m. (F) Quantitative analysis 
of polarity by percentage of spheroids without 
polarized distribution of basal  6 integrin. No sig-
nificant difference was found between Myr-Akt 
and vector control for each condition (mean   SD, 
P   0.05, Student’s t test; more than 600 colonies 
were analyzed for each condition from 3 indepen-
dent experiments). 
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structures (Fig. 2). This basolateral distribution of PI3K and
PIP3 might indeed reflect the localization of active cell sur-
face receptors, e.g., integrins and receptor tyrosine kinases,
many of which have particular functions when localized to
the basal or basolateral surfaces (Playford et al., 1996; Weaver
et al., 1997; Vermeer et al., 2003). Basolateral polarization of
PIP3 has been suggested to be a critical determinant of differ-
entiated tissue behavior in polarized MDCK cells grown as
monolayers on filters (Watton and Downward, 1999) or as
cysts in 3D collagen gels (Yu et al., 2003), and PIP3 becomes
apolarly distributed in the plasma membrane during branch-
ing morphogenesis (Yu et al., 2003), a process believed to in-
volve the transitory dedifferentiation to a migratory and in-
vasive state that is highly reminiscent of the malignant
phenotype. PI3K signaling polarization is also an essential
component of chemotactic migration in neutrophils and 
 
Dic-
tyostelium
 
 (Servant et al., 2000; Funamoto et al., 2002; Wang
et al., 2002b), and the directionality of neuronal axon growth
is controlled by spatially localized PI3K activity (Shi et al.,
2003). Our observations in mammary epithelial cells do not
reveal the extent to which the polarized distribution of PI3K
and PIP3 causes, or is the consequence of, tissue polarity, but
previous observations with these cells in 3D lrBM and with
MDCK cysts have suggested that formation of cell–cell con-
tacts is an essential component of ECM-induced cell polarity
(Weaver et al., 1997, 2002; Yeaman et al., 1999). If so, then
formation of tight junctions at points of cell–cell contact may
provide boundaries for localization of PI3K and other signal-
ing effectors such as integrins and growth factors that then
provide the polarizing principle. These possibilities are under
investigation.
We have found that the 3D presentation of lrBM is essen-
tial for coupling the expression levels and activity of EGFR
and 
 
 
 
1 integrin in cultured mammary epithelial cells (Wang
et al., 1998), and evidence in other systems also implicates
reorganization of signaling pathways in cells cultured in 3D
lrBM (Cukierman et al., 2001, 2002; Muthuswamy et al.,
2001). We now show that components of the PI3K signal-
ing pathway are involved in this cross-modulation process,
as phenotypic reversion by inhibition of PI3K is associated
with, and presumably, supported by, up-regulation of the
PI3K antagonist, PTEN (Fig. 3). This also requires the es-
tablishment of organized structures in 3D lrBM, as treat-
ment of T4-2 cells with PI3K inhibitors does not result in
up-regulation of PTEN when cells are grown on 2D plastic
substrata (Fig. 3 B). Given that the signaling reorganization
associated with reversion of T4-2 cells is associated with glo-
bal repolarization of signaling molecules, we suggest that di-
Figure 5. Expression of Rac1 disrupts tissue 
polarity but does not prevent proliferation arrest. 
(A) Rac1 activity correlates with PI3K activity, 
analyzed by using recombinant PAK-GST-CD 
fusion protein pulldown from lysates of 10-d 3D 
lrBM cultures of S-1, T4-2, and T4-2 LY cells. 
(B) Expression of constitutively active Rac1 L61, 
detected from lysates of cells infected with Rac1L61 
or vector control and probed with anti-HA antibody 
(left) or immunoprecipitated with anti-HA antibody 
and blotted by anti-Rac1 antibody (right). (C) Inhi-
bition of PI3K attenuates growth of both T4-2 Rac1 
L61 colonies and control (T4-2 Vector) colonies, as 
assessed by phase contrast microscopy. Bar, 20  m. 
(D) Analysis of total nuclear number at spheroid 
cross section reveals that treatment with LY294002 
causes statistically signinficant decrease of colony 
cell number, but expression of Rac1L61 causes no 
substantial difference (mean   SD, P values calcu-
lated using Student’s t test; more than 300 colonies 
were analyzed from 3 independent experiments for 
each condition). (E) Attenuation of PI3K activity does 
not restore tissue polarity in T4-2 cells that express 
Rac1 L61, as assessed by immunofluorescence of 
vector control or transfected cells, stained with 
antibody against  6 integrin and with DAPI. Bar, 
10  m. (F) Statistical analysis of data in E, in which 
polarity was assessed by percentage of spheroids 
without polarized distribution of  6 integrin at basal 
surface (mean   SD, P   0.01, vector control versus 
Rac1 L61 cells treated with LY294002, Student’s 
t test; more than 700 colonies were analyzed for 
each condition from 3 independent experiments). 
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rectional orientation of signaling is an essential component
of the cross-modulation process. In this regard, it is tempt-
ing to speculate that the 3D lrBM–directed basal localiza-
tion of PI3K and PIP3 may explain why the cells in the
outer layer of acini are more resistant to apoptosis than those
not in contact with 3D lrBM (Debnath et al., 2002).
High expression of PI3K is commonly found in cancers
and cancer cell lines (Vivanco and Sawyers, 2002; Wang et
al., 2002a), and there is considerable evidence that the activ-
ity of this enzyme is a key component of the tumorigenic
process. Cowden syndrome (an autosomal-dominant cancer
predisposition syndrome caused by inherited mutations in
PTEN) causes elevated risk of breast, thyroid, and skin tu-
mors (Liaw et al., 1997); mice made heterozygous for ex-
pression of PTEN develop cancers at multiple sites (Di Cris-
tofano et al., 1998), and transgenic mice deficient for PTEN
expression in the mammary gland developed tumors at early
stage (Li et al., 2002). Recent experiments using immortal-
ized human mammary epithelial cells has shown that early
passage cells require transfection of additional oncogenes
along with PI3K (or Rac1/Akt) to become malignant,
whereas late passage cells (which presumably accumulate
more alterations) can be transformed with only PI3K (or
Rac1/Akt) (Zhao et al., 2003); these results are also consis-
tent with our model in which additional abnormalities must
exist in addition to PI3K activation in order for HMT3522
mammary epithelial cells to become tumorigenic. Overex-
pression of constitutively active Akt in T lymphocytes, pan-
creatic cells, and the mammary gland increases cellular pro-
liferation and promotes survival but does not induce cellular
transformation or increase tumor incidence (Vivanco and
Sawyers, 2002), suggesting that additional factors must be
required. Rac1 isoforms are overexpressed in cancers of the
breast and other organs, and increased activity of Rac1 or
Rac3 has been found in breast carcinoma cell lines and Ras-
transformed breast epithelial cells (Mira et al., 2000; Sahai
and Marshall, 2002). Here, we have unified the roles of ele-
vated Rac1 and Akt activities in a simple mechanistic frame-
work: we have found that the high levels of PI3K in T4-2
cells contribute to the loss of polarity and increased prolifer-
ation through Akt and Rac1, and we find that these path-
ways and phenomena are functionally separable. We find
that PI3K-Akt signaling is responsible for an appreciable in-
crease in cell proliferation (Fig. 4), whereas the PI3K-Rac1
signaling is responsible for the loss of basal tissue polarity
(Fig. 5), and that expression of both can completely prevent
reversion by LY294002. These results show that overactive
PI3K signaling activates these two effectors for separate but
Figure 6. Simultaneous expression of both Akt and 
Rac1 is sufficient to prevent reversion induced by 
attenuation of PI3K activity. (A) Expression of both 
constitutively active Akt (Myr-Akt) and Rac1 (Rac1 
L61) in T4-2 cells was detected by probing Western 
blots of cell lysates with anti-HA antibody. (B) PI3K 
inhibition fails to decrease proliferation and to 
restore tissue organization in Myr-Akt and Rac1 
L61-double transfectants, as assessed by phase 
contrast microscopy and (C) by increased nuclei 
per spheroid cross section (mean   SD, P values 
calculated using Student’s t test; more than 300 
colonies were analyzed for each condition from 
three independent experiments). Bar in B, 20  m. 
(D) Restoration of basal tissue polarity is disrupted 
in double transfectants, as assessed by aberrant 
location of  6 integrin in LY294002-treated T4-2 
Myr-Akt Rac1 L61 cells grown in 3D lrBM for 
10 d. Representative images from three independent 
experiments are shown. Bar, 10  m. (E) Myr-Akt 
and Rac1 L61 double transfectants collaborate to 
increase anchorage-independent cell growth and 
overcome the inhibitory effects of treatment with 
PI3K inhibitor. Transfectants were grown in methyl 
cellulose for 3 wk in the absence or presence of 
PI3K inhibitor. Representative images are shown 
from duplicate experiments. 
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collaborative regulation of the distinct cellular behaviors of
tumor tissues (Fig. 7). Significantly, our results also reveal
that increased cell proliferation (in the absence of a polarity-
disrupting signal) is not sufficient to result in loss of tissue
organization (Fig. 4 E), a finding that may explain why Akt
overexpression by itself is not sufficient to increase tumor in-
cidence as well.
In conclusion, we have used the 3D lrBM assay to deter-
mine the role of PI3K signaling in the tumorigenic phe-
notype, signaling reorganization, and tissue polarity of
 
mammary epithelial cells. Our discovery of asymmetric dis-
tribution of PI3K and PIP3 in these polarized acinus-like
structures strongly implies that they might act as spatial deter-
minants to regulate mammary epithelial polarity. Our eluci-
dation of the events downstream of PI3K sheds light on the
process by which increased proliferation and loss of tissue po-
larity act collaboratively to produce the malignant phenotype.
 
Materials and methods
 
Reagents and cell culture
 
lrBM from Englebreth-Holm-Swarm tumors (matrigel), Vitrogen (rat tail
collagen type I), and the antibodies for E-cadherin, 
 
 
 
1-integrin, EGFR, 
 
 
 
6
integrin, and Ki-67 were described previously (Weaver et al., 1997; Wang
et al., 1998). The other antibodies used in this study are: PTEN (clone 2),
Akt (clone 7), Rac1 (clone 102), PI3K p85 (clone 4), and p110 subunit
(clone 19) (Transduction Laboratory), HA (12CA5; Roche), Phospho-Akt
(serine 473 or threonine 308), total and phospho-GSK-3
 
 
 
 (serine 9), total
and phospho-p70 S6 kinase (threonine 389; Cell Signaling Technology),
PIP3 monoclonal antibody (Chen et al., 2002; clone RC6F8; Echelon
Corp.), and ZO-1 antibody (gift of Shoichiro Tsukita, Kyoto University Fac-
ulty of Medicine, Kyoto, Japan). HMT-3522 mammary epithelial cells were
cultured as described previously (Weaver et al., 1997; Wang et al., 1998).
The PI3K inhibitor LY294002 or wortmannin (Calbiochem) was dissolved
in DMSO and added to culture medium at the final concentration of 8 
 
 
 
M
or 2.5 nM after cells were plated; control cultures were treated with vehi-
cle only. Cells were treated with inhibitor or vehicle inside matrigel or on
tissue culture plates for 10 d and inhibition was maintained by replacing
with fresh medium containing inhibitor or vehicle every 2 d. No toxicity
was found during the 10-d treatment with LY294002 or wortmannin.
 
DNA constructs and gene transfection
 
A construct containing Rac1 L61–HA (gift of Tung C. Chan, Thomas Jeffer-
son University, Philadephia, PA) was digested with EcoRI and BamHI and
cloned into the pLXSN–Neo retroviral construct (CLONTECH Laboratories,
Inc.). The myr-Akt pWZL retroviral construct myr
 
 
 
4–129 (Kohn et al.,
1998) was provided by Richard Roth (Stanford University, Stanford, CA).
Transfection of Phoenix packaging cells (gift of Garry P. Nolan, Stanford
University) and production of retroviral stock were according to standard
protocols. The HMT-3522 mammary epithelial cells were infected at 40–
50% confluence. Myr-Akt and Rac1 L61-double transfectants were pro-
duced by sequentially infecting cells with each construct. The stably ex-
pressing cells were selected in the presence of neomycin (500 
 
 
 
g/ml) or
hygromycin B (50  g/ml) and surviving clones were pooled.
Immunoblotting, immunoprecipitation, and indirect 
immunofluorescence
Immunoblotting and indirect immunofluorescence were performed as de-
scribed previously (Weaver et al., 1997; Wang et al., 1998). For immuno-
precipitation, cells were lysed in IP buffer (1% Triton X-100, 150 mM NaCl,
10 mM Tris/HCl, pH 7.4, 1 mM EDTA, 1 mM EGTA, 2 mM NaF, 1 mM so-
dium orthovanadate, 10  g/ml leupeptin, 10  g/ml pepstatin, 10  g/ml
aprotinin, 10  g/ml E 64, and 1 mM Pefabloc) and centrifuged at 16,000 g
at 4 C. Equal amounts of protein lysates were precleared by 50  l of protein
G plus–conjugated agarose beads (Santa Cruz Biotechnology, Inc.) before
the addition of 1  g of primary antibody. Samples were incubated at 4 C
with gentle rotation for 1 h. Subsequently, samples were incubated with 30
 l of protein G plus–conjugated beads for 1 h at 4 C. The beads were
washed three times with IP buffer before being heated with sample buffer at
95 C for 5 min and analyzed by SDS-PAGE and Western blotting.
For Rac1 activity assay, the cells from 10-d culture in 3D BM were lysed
in GST-Fish buffer (10% glycerol, 50 mM Tris, pH 7.4, 100 mM NaCl, 1%
NP-40, 2 mM MgCl2, 10  g/ml leupeptin, 10  g/ml pepstatin, 10  g/ml
aprotinin, 10  g/ml E 64, and 1 mM Pefabloc) and centrifuged at 16,000 g
at 4 C. Equal amounts of protein supernatants were incubated with recom-
binant GST-PAK-CD fusion protein (containing the Rac and Cdc42 binding
region from human PAK1; Sander et al., 1998), bound to glutathione-cou-
pled Sepharose beads (Amersham Biosciences) at 4 C for 30 min. The
beads were washed with an excess of lysis buffer, eluted in sample buffer,
and then analyzed by SDS-PAGE and Western blotting using antibody
against Rac1.
For PIP3 immunofluorescence, the isolated colonies were fixed with
3.7% formaldehyde, washed with CSK buffer (10 mM Hepes, 138 mM
Figure 7. Scheme of proposed tumor cell signaling network to 
control polarity, proliferation, and apoptosis. T4-2 signaling net-
work. PI3K activity is increased in tumor cells as a result of aberrant 
signaling from cell–ECM and cell–growth factor receptor interactions. 
The consequent activation of Akt contributes to the increased cellular 
proliferation through downstream pro-proliferation and anti-apoptotic 
pathways. Increased PIP3 also leads to up-regulation of Rac1 through 
activation of Rac1-specific GEF activity, resulting in altered organi-
zation of the actin cytoskeleton, formation and maintenance of tight 
junctions, and directionality of vesicle trafficking, effects that combine 
to disorganize the tissue structure. Thus, each pathway independently 
affects cellular behavior, but the synergistic effect leads to the tumor 
phenotype. ( ) Cross-modulation in 3D lrBM. Inhibition at any of 
these pressure points results in normalization of the expression and 
activity at each of the other points, with concomitant normalization 
of downstream signaling pathways.The roles of Akt and Rac1 in tumor phenotype | Liu et al. 611
KCl, 3 mM MgCl2, 1 mM EDTA), permeabilized by 0.1% Triton X-100 in
CSK buffer, and blocked with 3% skim milk in blocking buffer (50 mM
Tris/HCl, pH 7.5, 1 mM CaCl2). Primary antibody diluted 1:100 in block-
ing buffer was incubated with samples for 1 h in room temperature fol-
lowed by FITC-conjugated secondary antibody.
Nuclei were counterstained with DAPI (Sigma-Aldrich). Control sec-
tions were stained with secondary antibodies only. The slides were sealed
with Vectashield (Vector Laboratories). The images were collected with
Zeiss 410 LSM confocal microscope (Zeiss Pluar 40  oil objective lenses;
Carl Zeiss MicroImaging, Inc.) or RT SLIDER SPOT digital camera (SPOT
RT v3.2 software; Diagnostic Instruments) attached to Zeiss Photomicro-
scope III (Zeiss Plan-Neofluar 40  oil objective lenses; Carl Zeiss Micro-
Imaging, Inc.). Images for figures were colored and resized with Adobe
Photoshop 7.0 software.
Anchorage-independent growth assays
For soft agar assay, 5,000 cells were plated in 1 ml of DME/F12 containing
0.3% agarose, overlaid with 1 ml of 1% agarose, and then exposed to
treatment as indicated. Cultures were maintained for 15 d. Colonies from
duplicated wells were measured and scored positive when the colony
sizes exceeded a diameter of 50  m.
For methyl cellulose anchorage–independent growth assay, 100,000
cells were seeded per 60-mm dishes in 5 ml of DME/F12 containing 1.5%
methyl cellulose (Fisher Scientific) with inhibitor or vehicle only. Colonies
were scored after 3 wk.
Online supplemental material
Supplemental figures show the following results; treatment of T4-2 cells
with PI3K inhibitor LY294002 at 8- M concentration when grown in 3D
lrBM for 10 d does not affect cell viability or lead to increased cell death
(Fig. S1 A); the same treatment decreases cell proliferation of T4-2 cells
when cultured on 2D plastic (Fig. S1 B); expression of constitutively active
Rac1 V12 in T4-2 cells transduced by adenovirus inhibits LY294002-
induced repolarization of basal marker  6 integrin in 3D lrBM (Fig. S1 C);
treatment of T4-2 cells with PI3K inhibitor does not change its expression
levels (Fig. S2 A); overexpression of constitutively active Akt in T4-2 cells
greatly increases anchorage-independent growth of T4-2 cells in soft agar
(Fig. S2 B); and PIP3 staining intensity is significantly reduced when treat-
ing T4-2 cells with PI3K inhibitor (Fig. S2 C). Figs. S1 and S2 are available
at http://www.jcb.org/cgi/content/full/jcb.200306090/DC1.
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